The Effect of Training and Follow-up Given to Cancer Patients Receiving Chemotherapy According to the Neuman Systems Model on the Development of Oral Mucositis and Perceptions of Comfort in Patients
1 other identifier
interventional
94
1 country
1
Brief Summary
It is aimed to prevent the development of oral mucositis or to reduce the severity of developing oral mucositis with the training to be given to patients receiving chemotherapy according to the Neuman systems model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Nov 2023
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedJanuary 31, 2024
January 1, 2024
2 months
August 6, 2023
January 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Comfort Perception Scale in Oral Mucositis
The scale was developed in 2019 by Erden and İpek Çoban to evaluate the perception of comfort in patients with oral mucositis. The scale consists of 31 items and 2 sub-dimensions.
12 week
Oral Mucositis Grading Index:
Developed by the World Health Organization and It is a staging scale. Grade 0: No symptoms. Grade 1: Pain or erythema. Grade 2: Painful, erythema, edema or ulcer present, but the patient can take solid foods. Grade 3: There is pain, erythema, edema or ulcer, the patient can only take liquid foods. Grade 4: No feeding.
12 week
Study Arms (2)
Experimental
EXPERIMENTALTraining and Follow-up According to the Neuman Systems Model
Control
NO INTERVENTIONonly procedure will be applied
Interventions
Neuman Systems Model (NSM) it presents a holistic approach to patients by including physiological, spiritual, sociocultural and five major developmental variables
Eligibility Criteria
You may qualify if:
- Receiving chemotherapy treatment No mental or communication problems, Volunteering to participate in research. having internet, Having at least primary education level, Being able to use smart phone and internet. Being on treatment that causes methotrexate, Cispilatin, Cyclophoshamide, 5-fluorouracil group oral mucositis.
You may not qualify if:
- lack of internet illiteracy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atatürk university nursing faculty
Erzurum, Center, 25240, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülcan B.TURAN
Firat University
- PRINCIPAL INVESTIGATOR
Yasemin Erdem
Erzurum Technical University
- PRINCIPAL INVESTIGATOR
Seda Karaman
Atatatürk Üniversitesi
Central Study Contacts
Yasemin Erdem
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 6, 2023
First Posted
August 14, 2023
Study Start
November 1, 2023
Primary Completion
January 1, 2024
Study Completion
July 1, 2024
Last Updated
January 31, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share